What investment strategy does Paluel-Marmont Capital focus on?

Paluel-Marmont Capital focuses on Buyout, Growth strategies in the private equity space.

How many portfolio companies does Paluel-Marmont Capital have?

Paluel-Marmont Capital has 5 active portfolio companies and 5 completed exits and 2 funds tracked on GP Intel.

Where is Paluel-Marmont Capital headquartered?

Paluel-Marmont Capital is headquartered in Paris, France.

What is Paluel-Marmont Capital's assets under management?

Paluel-Marmont Capital manages approximately €100M in assets under management.

When was Paluel-Marmont Capital founded?

Paluel-Marmont Capital was founded in 1992.

What sectors does Paluel-Marmont Capital invest in?

Paluel-Marmont Capital invests across Business Services, Consumer, Software, Industrials.

What are Paluel-Marmont Capital's recent exits?

Recent realized exits by Paluel-Marmont Capital include: Bugbusters (2025) to Securinfor; Sogetrel (2021) to Latour Capital and Andera Partners; Tridem Pharma (2017) to Fosun Pharma; Anaveo (2016) to Bridgepoint Development Capital; Avidom (2016) to Azulis Capital.

Home/GPs/Paluel-Marmont Capital

DetailCard

Paluel-Marmont Capital

Paris, France·Founded 1992·

Buyout Growth Equity

·paluel-marmont-capital.fr

Private-equity arm of Compagnie Lebon (listed on Paris Bourse since 1854), formalised as a separate vehicle in 1992 by the Paluel-Marmont family; manages around EUR 100M across two funds focused on French SMEs with EUR 5-15M tickets in companies generating EUR 10-150M revenue, plus the Paluel-Marmont Investissement (PMI) family-office syndication platform.

AUM

€100M

Funds

vintages 2010–2018

Portfolio

Exits

Paluel-Marmont Capital is a Paris buyout firm with €100M AUM, 5 active companies and 5 exits.

SectorsBusiness Services Consumer Software Industrials

Sector breakdown

10 companies

Industrials

2 · 20%

Business Services

2 · 20%

TMT

1 · 10%

IT Services

1 · 10%

Healthcare

1 · 10%

Telecom

1 · 10%

Gaming

1 · 10%

Pharma

1 · 10%

Key facts

HQParis, France

Founded1992

Websitepaluel-marmont-capital.fr

Recent exits

Paluel-Marmont Capital sold Bugbusters to Securinfor in 2025 after less than a year.

Paluel-Marmont Capital sold Sogetrel to Latour Capital and Andera Partners in 2021 after 3 years.

Paluel-Marmont Capital sold Tridem Pharma to Fosun Pharma in 2017 after 6 years.

Paluel-Marmont Capital sold Anaveo to Bridgepoint Development Capital in 2016 after 3 years.

Coverage notes

2 funds tracked, 10 portfolio companies (5 active · 5 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Paluel-Marmont Capital has raised, with its portfolio companies. Hand-checked from public filings.

2 funds

Fund

Strategy

Vintage

Size

Assets

Exits

PMC

Buyout2018€100M2 assets1 exits

Buyout

2018 · 8yr

€100M

Unrealized

2 held

Company	Entry
Ief2i Industrials · France	2021
Securinfor IT Services · France	2019

Realized

1 exit

Company	Entry	Exit	Type	Buyer	MOIC
Bugbusters TMT · France	2025	2025	Trade Sale	Securinfor	–

Paluel-Marmont Capital Fund

Growth2010€41M3 assets4 exits

Growth

2010 · 16yr

€41M

Unrealized

3 held

Company	Entry
Quadrilatere Business Services · France	2019
Snetor Industrials · France	2020
TapNation Gaming · France	2023

Realized

4 exits

Company	Entry	Exit	Type	Buyer	MOIC
Anaveo Business Services · France	2013	2016	Trade Sale	Bridgepoint Development Capital	–
Avidom Healthcare · France	2012	2016	Secondary	Azulis Capital	–
Sogetrel Telecom · France	2018	2021	Secondary	Latour Capital and Andera Partners	–
Tridem Pharma Pharma · France	2011	2017	Trade Sale	Fosun Pharma	–

About Paluel-Marmont Capital

Paluel-Marmont Capital is the private equity arm of Compagnie Lebon (listed on Paris Bourse since 1854), formalised as a separate vehicle in 1992 by the Paluel-Marmont family with €100 million of assets under management. The firm manages two funds focused on French SMEs with €5-15 million equity tickets, leveraging the multi-decade Compagnie Lebon investment heritage.

Investment thesis

Paluel-Marmont Capital targets French SMEs aligned with the Compagnie Lebon family-office heritage, deploying equity tickets typically ranging from €5 million to €15 million per transaction. Sector focus spans Business Services, Industrials and selectively other French SME verticals, with the family-office structure enabling long-duration patient capital deployment alongside management teams across multi-year holding periods.

Recent activity

The platform tracks 2 funds, 3 active portfolio companies and 4 realised exits across the multi-vintage Paluel-Marmont family programme. The long-tenure Compagnie Lebon listed heritage (since 1854) underpins institutional credibility and patient capital alignment with French SME ecosystems.

Frequently asked questions

What investment strategy does Paluel-Marmont Capital focus on?: Paluel-Marmont Capital focuses on Buyout, Growth strategies in the private equity space.
How many portfolio companies does Paluel-Marmont Capital have?: Paluel-Marmont Capital has 5 active portfolio companies and 5 completed exits and 2 funds tracked on GP Intel.
Where is Paluel-Marmont Capital headquartered?: Paluel-Marmont Capital is headquartered in Paris, France.
What is Paluel-Marmont Capital's assets under management?: Paluel-Marmont Capital manages approximately €100M in assets under management.
When was Paluel-Marmont Capital founded?: Paluel-Marmont Capital was founded in 1992.
What sectors does Paluel-Marmont Capital invest in?: Paluel-Marmont Capital invests across Business Services, Consumer, Software, Industrials.
What are Paluel-Marmont Capital's recent exits?: Recent realized exits by Paluel-Marmont Capital include: Bugbusters (2025) to Securinfor; Sogetrel (2021) to Latour Capital and Andera Partners; Tridem Pharma (2017) to Fosun Pharma; Anaveo (2016) to Bridgepoint Development Capital; Avidom (2016) to Azulis Capital.